Eledon PharmaceuticalsELDN
13F holders, Q2 2024 (June 30)32holders +3
7new positions
4sold out
1famous investor
$2.64avg. 13F price*
At the end of Q2 2024, 32 institutions reported holding Eledon Pharmaceuticals Inc. (ELDN) in their 13F filings, up 3 from Q1 2024. 7 opened new positions and 4 sold out. The largest holders were BVF Inc. ($16.6M), Armistice Capital, LLC ($6.2M) and Zimmer Partners, LP ($5.6M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Eledon Pharmaceuticals Inc.
- CUSIP
- 28617K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $12.1M |
| Exits | 4 | $62K |
All 13F filers, Q1 2024 → Q2 2024: 8,772,807 shares bought and 108,058 shares sold, net +8,664,749 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| BVF Inc. | 0.47% | Add +45.5% | 6,293,282 | $16.6M |
| Armistice Capital, LLC | 0.16% | Add +1.7% | 2,336,000 | $6.2M |
| Zimmer Partners, LP | 0.11% | New | 2,109,704 | $5.6M |
| Schonfeld Strategic Advisors LLC | 0.03% | Add +2852.8% | 1,500,000 | $4.0M |
| Sphera Funds Management LTD. | 0.56% | New | 1,297,021 | $3.4M |
| Vanguard Group Inc. | 0.00% | Add +14.0% | 1,104,395 | $2.9M |
| Woodline Partners LP | 0.02% | Add +3.6% | 675,243 | $1.8M |
| Nantahala Capital Management, LLC | 0.16% | New | 600,000 | $1.6M |
| Alyeska Investment Group, L.P. | 0.01% | New | 500,000 | $1.3M |
| Ensign Peak Advisors, Inc | 0.00% | No change | 443,001 | $1.2M |
| Geode Capital Management, LLC | 0.00% | Add +90.4% | 344,489 | $910K |
| State Street Corp. | 0.00% | Add +261.3% | 161,492 | $426K |
| CM Management, LLC | 0.39% | No change | 160,000 | $422K |
| BlackRock Inc. | 0.00% | Add +478.0% | 155,080 | $409K |
| Renaissance Technologies | 0.00% | Add +57.1% | 136,773 | $361K |
| Northern Trust Corp. | 0.00% | Add +130.9% | 91,893 | $243K |
| Jmac Enterprises LLC | 0.03% | No change | 58,041 | $153K |
| UBS Group AG | 0.00% | Add +1374925.0% | 55,001 | $145K |
| Ingalls & Snyder LLC | 0.01% | No change | 51,849 | $137K |
| Bridgeway Capital Management, LLC | 0.00% | New | 33,400 | $88K |
| Marco Investment Management LLC | 0.01% | Add +22.3% | 30,344 | $80K |
| Dimensional Fund Advisors LP | 0.00% | New | 30,233 | $80K |
| Susquehanna International Group, LLP | 0.00% | Reduce -78.2% | 21,788 | $58K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +198.9% | 16,958 | $45K |
| Mercer Global Advisors Inc. | 0.00% | No change | 16,726 | $44K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 14,987 | $40K |
| Pathstone Holdings, LLC | 0.00% | No change | 13,029 | $34K |
| Bank of America Corp. | 0.00% | New | 6,818 | $18K |
| Morgan Stanley | 0.00% | No change | 2,155 | $6K |
| JPMorgan Chase & Co. | 0.00% | Add +62.5% | 91 | $240 |
| FMR LLC | 0.00% | No change | 17 | $45 |
| Royal Bank of Canada | 0.00% | No change | 40 | $0 |
"% of holder's portfolio" is ELDN's weight in each manager's 13F, not the share of Eledon Pharmaceuticals Inc. the manager owns.